Vicore Pharma Holding AB (publ) (STO:VICO)
Sweden
· Delayed Price · Currency is SEK 10.28
-0.08 (-0.77%)
At close: Dec 5, 2025
Vicore Pharma Holding AB Revenue
Vicore Pharma Holding AB had revenue of 760.00K SEK in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to 8.50M, down -91.85% year-over-year. In the year 2024, Vicore Pharma Holding AB had annual revenue of 109.35M.
Revenue (ttm)
8.50M
Revenue Growth
-91.85%
P/S Ratio
340.44
Revenue / Employee
236.14K
Employees
29
Market Cap
2.89B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 27.85B |
| Getinge AB | 35.85B |
| Sectra AB | 3.37B |
| Camurus AB | 2.35B |
| Asker Healthcare Group AB | 16.41B |
| Medicover AB | 25.67B |
| BioArctic AB | 1.92B |
| AddLife AB | 10.53B |